Pill Pushers' Paperwork: FDA Seeks Input on Drug Distributor Checks
Published Date: 2/20/2026
Notice
Summary
The FDA wants your thoughts on how it collects info about groups that check and license drug wholesalers and delivery companies. This helps keep medicine safe and the supply chain strong. If you’re involved or interested, send your comments by April 21, 2026—no cost to join, just your voice!
Analyzed Economic Effects
4 provisions identified: 0 benefits, 4 costs, 0 mixed.
Third Parties Can Drive Licenses
FDA will allow approved third-party organizations (AOs) to perform licensure reviews and inspections for wholesale drug distributors and third-party logistics providers (3PLs). FDA says it can rely on AO reports when deciding whether to issue a license under sections 583(c) and 584(d)(2)(A) of the FD&C Act.
Paperwork Burden Hours Estimated
FDA estimates the annual reporting burden as 15 respondents, 279 total responses, and 1,386 total hours. FDA also estimates recordkeeping as 18 recordkeepers, 102 total records, and 204 total hours per year for these collections under 21 CFR part 205.
7-Day AO Inspection Report Deadline
When an AO inspects a 3PL facility, the AO must provide FDA with an inspection report within 7 days after completion of the inspection. FDA will use the AO's report to make the final licensing decision for the facility.
AOs Must Keep Records Five Years
FDA proposes that an approved organization (AO) must maintain certain records for at least 5 years and make those records readily available to FDA upon request. This recordkeeping requirement applies as a condition of keeping AO approval.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2026-03332, Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice
The FDA wants to hear from juice makers and importers about their rules for keeping juice safe and clean using special safety checks called HACCP. They’re asking for comments by April 21, 2026, to help decide if they should keep or change these rules. This affects anyone who processes or imports fruit and vegetable juices and helps keep your juice safe without adding extra costs.
Next: 2026-03334, Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Make a Number of Technical, Non-Substantive Changes to Its Rulebook
Cboe Exchange is updating its rulebook with a bunch of small, technical fixes that don’t change any big rules. These tweaks help keep everything clear and running smoothly for traders and the Exchange itself. The changes took effect right away on February 10, 2026, and won’t cost anyone extra or change how trading works.